Having trouble viewing this email? View in your browser.
ESCMID Logo

4 September 2018
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.

 

Attendance Grants available for ESGAP course in Madrid

The ESCMID Study Group for Antimicrobial stewardshiP (ESGAP) offers a workshop in antibiotic therapy, for the fourth time, in Madrid from February 7-9, 2019.

The full program and details can be found at: www.antibioticscourse.com

ESCMID offers 10 attendance grants to its members. These grants cover the registration cost (but not travel or accommodation). To apply for an attendance grant, click here.

The closing date for the grant application is November 1st 2018.

› Read more
 

New publication from ESGFOR: Post-mortem microbiology in sudden death: sampling protocols proposed in different clinical settings.

Autopsies are an essential tool to investigate and establish the cause of death. When a patient dies from an infection, microbiology is decisive to identify the causative pathogen. Post-mortem microbiology (PMM) aims to: detect infections causing sudden deaths; confirm clinically suspected but unproven infection; evaluate the efficacy of antimicrobial therapy; identify emergent pathogens; and recognize medical errors. Additionally, the analysis of the thanatomicrobiome may be useful to estimate the post-mortem interval. A multidisciplinary team with experts in microbiology and autopsies on behalf of the ESGFOR (ESCMID - European Society of Clinical Microbiology and Infectious Diseases - study group of forensic and post-mortem microbiology and in collaboration with the ESP -European Society of Pathology-) proposed this interesting review based on published literature and complemented with their own expertise to offer suggestions for PMM sample collection and to propose sampling guidelines for forensic microbiologists and pathologists facing different unexpected death scenarios.

› Read more
 

Nominations for the TAE Steering Committee are open until 17 September

In 2018 we are looking for new Trainee Association of ESCMID Steering Committee members with a background in Clinical Microbiology. The vacancies are for a three-year term starting in January 2019 and are to be filled with new members who will be elected in Autumn 2018. You can view the criteria here. The nomination platform is open until 17 September. Don`t miss this chance to be a part of a dynamic and international team of young scientists!

› Read more
 

CMI highlights: ESCMID white paper on clinical guidance documents

Aside from being essential for practicing clinicians, clinical guidance documents (CGD) serve also as educational and training tools, providing scientific background to clinical questions in a format that extends beyond national boundaries. As such, developing a CGD is a scientific endeavor, where a clear definition on the requirements of the document as well as a sound and transparent development process are needed to bring the project to successful completion. In this white paper by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), different types of ESCMID guidance documents are defined, and, for each of them (white papers, clinical practice guidelines, consensus statements, state-of-the-science statements, and position papers), the framework to be used during their development and publication described.

› Read more
 

Applications are now open for the WHO observership in December

You can find more information on our website on the objectives and selection criteria for the two-day observership at the WHO Regional Office for Europe, Division of Health Emergencies & Communicable Diseases (DEC) in Copenhagen, Denmark. The observership will take place on 10 and 11 December, 2018. The deadline for applications is 24 September at 12:00 noon CET.

› Read more
 

GARDP Webinar on Antibacterial Development

The Global Antibiotic R&D Partnership (GARDP) is hosting their third live webinar on September 11. In this webinar, David Shlaes will discuss development of antibacterial drugs targeting specific pathogens with Ian Friedland, Sumathi Nambiar, and Mair Powell. This group of leading experts will talk about the risks and practical challenges associated with developing a therapy for a low frequency event for which treatment must be initiated urgently.

This presentation will be followed by an interactive Q&A session. Register here: 

GARDP webinar registration

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.